<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:contributor>Nabanita Nag</dc:contributor>
  <dc:contributor>Christina M. Carlson</dc:contributor>
  <dc:contributor>Jay R. Schneider</dc:contributor>
  <dc:contributor>Dennis M. Heisey</dc:contributor>
  <dc:contributor>Christopher J. Johnson</dc:contributor>
  <dc:contributor>David M. Asher</dc:contributor>
  <dc:contributor>Luisa Gregori</dc:contributor>
  <dc:creator>Julie Nemecek</dc:creator>
  <dc:date>2013</dc:date>
  <dc:description>&lt;p&gt;&lt;span&gt;Rapid antemortem tests to detect individuals with transmissible spongiform encephalopathies (TSE) would contribute to public health. We investigated a technique known as protein misfolding cyclic amplification (PMCA) to amplify abnormal prion protein (PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;) from highly diluted variant Creutzfeldt-Jakob disease (vCJD)-infected human and macaque brain homogenates, seeking to improve the rapid detection of PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;&amp;nbsp;in tissues and blood. Macaque vCJD PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;&amp;nbsp;did not amplify using normal macaque brain homogenate as substrate (intraspecies PMCA). Next, we tested interspecies PMCA with normal brain homogenate of the southern red-backed vole (RBV), a close relative of the bank vole, seeded with macaque vCJD PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;. The RBV has a natural polymorphism at residue 170 of the PrP-encoding gene (N/N, S/S, and S/N). We investigated the effect of this polymorphism on amplification of human and macaque vCJD PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;. Meadow vole brain (170N/N PrP genotype) was also included in the panel of substrates tested. Both humans and macaques have the same 170S/S PrP genotype. Macaque PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;&amp;nbsp;was best amplified with RBV 170S/S brain, although 170N/N and 170S/N were also competent substrates, while meadow vole brain was a poor substrate. In contrast, human PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;&amp;nbsp;demonstrated a striking narrow selectivity for PMCA substrate and was successfully amplified only with RBV 170S/S brain. These observations suggest that macaque PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;&amp;nbsp;was more permissive than human PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;&amp;nbsp;in selecting the competent RBV substrate. RBV 170S/S brain was used to assess the sensitivity of PMCA with PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;&amp;nbsp;from brains of humans and macaques with vCJD. PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;&amp;nbsp;signals were reproducibly detected by Western blot in dilutions through 10&lt;/span&gt;&lt;span&gt;-12&lt;/span&gt;&lt;span&gt;&amp;nbsp;of vCJD-infected 10% brain homogenates. This is the first report showing PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;&amp;nbsp;from vCJD-infected human and macaque brains efficiently amplified with RBV brain as the substrate. Based on our estimates, PMCA showed a sensitivity that might be sufficient to detect PrP&lt;/span&gt;&lt;span&gt;TSE&lt;/span&gt;&lt;span&gt;&amp;nbsp;in vCJD-infected human and macaque blood.&lt;/span&gt;&lt;/p&gt;</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>10.1371/journal.pone.0078710</dc:identifier>
  <dc:language>en</dc:language>
  <dc:publisher>PLOS</dc:publisher>
  <dc:title>Red-backed vole brain promotes highly efficient &lt;i&gt;in vitro&lt;/i&gt; amplification of abnormal prion protein from macaque and human brains infected with variant Creutzfeldt-Jakob disease agent.</dc:title>
  <dc:type>article</dc:type>
</oai_dc:dc>